0.39% -0.0953

Flexion Therapeutics, Inc. (FLXN)

개요 뉴스 가격 이력 토론 예측 배당 이력

Relative Volume:

Flexion Therapeutics, Inc. Stock (FLXN) Company Profile

Flexion Therapeutics, Inc.

Financial (7363)

781-305-7777

10 Mall Road, Suite 301, Burlington

최신 SEC 제출 서류

FLXN's Discussions on Twitter

Compare FLXN vs VOO, IVV, SPY, VTI, QQQ

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
FLXN Flexion Therapeutics, Inc.	24.05	0	102.74M	-95.05M	-19.23M	-1.88
VOO Vanguard S P 500 Etf	712.37	1.05T	0	0	0	0.00
IVV Ishares Core S P 500 Etf	778.45	893.27B	0	0	0	0.00
SPY Spdr S P 500 Etf Trust	775.04	818.54B	0	0	0	0.00
VTI Vanguard Total Stock Market Etf	379.73	699.38B	0	0	0	0.00
QQQ Invesco Qqq Trust Series 1	737.74	493.40B	0	0	0	0.00

Flexion Therapeutics, Inc. Stock (FLXN) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2021-04-26	재개	Credit Suisse	Outperform
2021-04-07	재개	RBC Capital Mkts	Outperform
2020-08-20	개시	Goldman	Neutral
2020-07-31	개시	Oppenheimer	Outperform
2020-07-29	개시	Credit Suisse	Outperform
2020-06-25	개시	H.C. Wainwright	Buy
2020-05-27	개시	Guggenheim	Buy
2019-12-27	재확인	The Benchmark Company	Buy
2019-12-05	개시	Craig Hallum	Buy
2019-11-25	개시	BTIG Research	Buy
2019-05-09	업그레이드	The Benchmark Company	Hold → Buy
2019-01-04	재확인	Needham	Buy
2019-01-04	다운그레이드	The Benchmark Company	Buy → Hold
2018-06-28	개시	The Benchmark Company	Buy
2017-10-09	재확인	Needham	Buy
2017-08-24	개시	Northland Capital	Outperform
2016-12-22	개시	Raymond James	Strong Buy
2016-09-06	재개	Lake Street	Buy
2016-07-21	개시	Lake Street	Buy
2016-05-03	재개	Wells Fargo	Outperform
2015-11-04	개시	Cantor Fitzgerald	Buy
2015-09-09	재확인	Needham	Buy

Flexion Therapeutics, Inc. 주식(FLXN)의 최신 뉴스

Flexion Therapeutics, Inc. (FLXN) 재무 분석

Flexion Therapeutics, Inc. (FLXN)

Flexion Therapeutics, Inc. Stock (FLXN) Company Profile

Compare FLXN vs VOO, IVV, SPY, VTI, QQQ

Flexion Therapeutics, Inc. Stock (FLXN) Upgrades & Downgrades

Flexion Therapeutics, Inc. 주식(FLXN)의 최신 뉴스

Top ETFs: Live Prices, Returns & Trends - TradingKey

First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds - Business Wire

FLXR And BINC: Both Diversified, Higher-Quality Bond ETFs, Both Buys - Seeking Alpha

First Trust Announces Adjournment of Special Shareholder Meeting for First Trust Active Global Quality Income ETF - Yahoo Finance

First Trust Announces Adjournment of Special Shareholder Meeting for First Trust Active Global Quality Income ETF - Yahoo Finance

FLXN | Horizon Flexible Income ETF Insider Trading - Quiver Quantitative

Emerging Sub-Segments Transforming the Viscosupplementation Market Landscape - openPR.com

Kolon’s cell-based gene therapy fails ph.3 osteoarthritis test - Fierce Biotech

Precision Trading with Blackrock Flexible Income Etf (BINC) Risk Zones - Stock Traders Daily

Joint Pain Injections Market Report Examines Industry Trends, Growth Drivers And Future Outlook - openPR.com

Osteoarthritis Market Expected to Showcase Moderate Growth at a CAGR of 3% During the Forecast Period (2026–2036) Driven by Emerging Therapies and Rising Disease Burden | DelveInsight - Business Upturn

Osteoarthritis Therapeutics Market Size & Share | Forecast Report 2035 - Research Nester

Tempest Therapeutics appoints two directors to board By Investing.com - Investing.com Australia

Tempest Therapeutics appoints two directors to board - Investing.com UK

Tempest Therapeutics appoints two directors to board By Investing.com - Investing.com India

Tempest Therapeutics (NASDAQ: TPST) CFO to depart while two independent directors join board - Stock Titan

Tempest Therapeutics appoints two directors to board - Investing.com

Tempest Therapeutics appoints two directors to board By Investing.com - Investing.com Canada

Tempest Therapeutics appoints two directors to board By Investing.com - Investing.com UK

Tempest Therapeutics Appoints Drake Richey and John Yee, MD, MPH to Board of Directors - The Manila Times

Tempest Therapeutics Appoints Drake Richey and John Yee, MD, MPH to Board of Directors - GlobeNewswire

Tempest Therapeutics Appoints Drake Richey and John Yee, MD, MPH to Board of Directors - Yahoo Finance Singapore

The Best Bond Funds in 2026 - Morningstar

Osteoarthritis Market Gains Momentum with Expanding Pipeline and Investment Potential by 2036 – DelveInsight | Merck KGaA, Peptinov, LG Chem, Akan Bioscience, BioTissue,Inc., Eupraxia Pharma - Barchart.com

FLXN Stock Price, Quote & Chart | HORIZON FLEXIBLE INCOME ETF (NYSEARCA:FLXN) - ChartMill

Top Players and Competitive Dynamics in the Osteoarthritis Therapeutics Market - openPR.com

BINC Can Help Stabilize The Portfolio’s Future Returns (NYSEARCA:BINC) - Seeking Alpha

Knee Osteoarthritis Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Domain | DelveInsight - Barchart.com

Knee Osteoarthritis Clinical Trial Pipeline Appears Robust - openPR.com

Versant Side Fund III L P Net WorthInsider Trades and Bio as of Apr 23, 2026 - Benzinga

Analysis of Key Market Segments Driving the Joint Pain Injections Market - openPR.com

Flexion Therapeutics, Inc.Common Stock (NY: FLXN - The Chronicle-Journal

Akin Advises Pharmakon in $100 Million Debt Financing for Paratek Pharmaceuticals and Radius Health Combination - akingump.com

Paratek Pharmaceuticals to Combine with Radius Health, Expanding Its Multi-Product Specialty Commercial Platform - Sixth Street

Activist hedge fund pushes Pacira BioSciences to sell itself - The Business Journals

Intra-Articular Injections Market Companies, Size & Trends 2026-2035 - Precedence Research

BINC: Actively Managed Multi-Sector Income, Built For Carry (NYSEARCA:BINC) - Seeking Alpha

Record January ETF Flows Highlight Rotation Away From Concentration - ETF Database

PCRX Stock Down 10% as Preliminary Q4 Revenues Miss Estimates - Finviz

Meredith Marlin Appointed as SVP, Total Rewards at Regeneron - hrtoday.in

The Standing Forward Flexion Test in Manual Therapy: A Critical Review and a Functional Reinterpretation - Cureus

Osteoarthritis Therapeutics Market Size to Hit USD 26.31 billion by 2035 - Precedence Research

Biotech Companies Hire New Legal Leadership - BioXconomy

PepGen Appoints Joseph Vittiglio, Esq., as Chief Business and Legal Officer - Business Wire

Horizon Announces Acquisition of Anfield Capital Management - Business Wire

What’s a Safe Retirement Withdrawal Rate for 2026? - Morningstar

Your retirement income journey: Why your withdrawal rate will change over time - Moneyweb

Horizon NASDAQ-100 Defined Risk ETF (QGRD) Stock Price, News, Quote & History - Yahoo! Finance Canada

Unlock a Worry-Free Retirement With ETFs - Investopedia

Horizon Flexible Income ETF (FLXN) Stock Price, News & Analysis - Stock Titan

Flexion Therapeutics, Inc. (FLXN) 재무 분석

매출

순이익

현금흐름

주당 순 이익

FLXN과 유사한 종목